GHU URO5 .pdf - Service d'Urologie CHU Henri Mondor

Annexe : publications récentes du service d’Urologie de
l’Hôpital Henri Mondor
Bakkar AA, Wallerand H, Radvanyi F, Lahaye JB, Pissard S, Lecerf L, Kouyoumdjian JC,
Abbou CC, Pairon JC, Jaurand MC, Thiery JP, Chopin DK, de Medina SG.
FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell
carcinoma of the bladder.
Cancer Res. 2003 Dec 1;63(23):8108-12.
Makhoul B, De La Taille A, Vordos D, Salomon L, Sebe P, Audet JF, Ruiz L, Hoznek A,
Antiphon P, Cicco A, Yiou R, Chopin D, Abbou CC.
Laparoscopic radical nephrectomy for T1 renal cancer: the gold standard A
comparison of laparoscopic vs open nephrectomy.
BJU Int. 2004 Jan;93(1):67-70.
Romis L, Cindolo L, Patard JJ, Messina G, Altieri V, Salomon L, Abbou CC, Chopin D,
Lobel B, de La Taille A.
Frequency, clinical presentation and evolution of renal oncocytomas: multicentric
experience from a European database.
Eur Urol. 2004 Jan;45(1):53-7
Salomon L, Saint F, Anastasiadis AG, Sebe P, Chopin D, Abbou CC.
Combined reporting of cancer control and functional results of radical
prostatectomy.
Eur Urol. 2003 Dec;44(6):656-60.
Cindolo L, de la Taille A, Messina G, Romis L, Abbou CC, Altieri V, Rodriguez A,
Patard JJ.
A preoperative clinical prognostic model for non-metastatic renal cell carcinoma.
BJU Int. 2003 Dec;92(9):901-5.
Salomon L, Anastasiadis A, Saint F, De La Taille A, Chopin D, Abbou CC.
Introducing a new, simple scoring system to evaluate oncological and functional
outcome after radical prostatectomy.
Scand J Urol Nephrol. 2003;37(5):392-5.
Saint F, Kurth N, Maille P, Vordos D, Hoznek A, Soyeux P, Patard JJ, Abbou CC, Chopin
DK.
Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guerin response of
superficial bladder cancer during induction course and maintenance therapy.
Int J Cancer. 2003 Nov 10;107(3):434-40.
Daher A, de Boer WI, El-Marjou A, van der Kwast T, Abbou CC, Thiery JP, Radvanyi F,
Chopin DK.
Epidermal growth factor receptor regulates normal urothelial regeneration.
Lab Invest. 2003 Sep;83(9):1333-41.
96